Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

GLUEGLUE
Showing 8 of 20 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in MONTE ROSA THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 616,310 shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $14.9M as of 2026-Q2. The position was increased (+12.7% shares). GLUE represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$14.9M

Current Shares

616,310

Total Value Change

+$13.1M

Total Shares Change

+269,812

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
616,310
+12.7%
$14.9M0.0%$24.20
32
2026-Q1
Increased
546,689
+21.8%
$9M0.0%$17.96
33
2025-Q4
Increased
448,714
+17.1%
$7M0.0%$15.97
32
2025-Q3
Increased
383,268
+0.5%
$2.8M0.0%$7.31
26
2025-Q2
Increased
381,337
+5.5%
$1.7M0.0%$4.60
27
2025-Q1
Decreased
361,535
-2.4%
$1.7M0.0%$5.10
0
2024-Q4
Increased
370,472
+6.9%
$2.6M0.0%$7.02
28
2024-Q3
Increased
346,498
+11.1%
$1.8M0.0%$5.17
29

Other major holders of GLUE: BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used